Large‐scale multiplex polymerase chain reaction assay for diagnosis of viral reactivations after allogeneic hematopoietic stem cell transplantation

Viral reactivations following hematopoietic stem cell transplantation are thought to result from the breakdown of both cell‐mediated and humoral immunity. As a result, many viruses could be reactivated individually or simultaneously. Using a multiplex polymerase chain reaction (PCR), we prospectively examined many kinds of viral DNAs at a time in 105 patients who underwent allogeneic hematopoietic stem cell transplantation. In total, 591 whole blood samples were collected weekly from pre‐ to 42 days post‐transplantation and the following 13 viruses were tested; herpes simplex virus 1 (HSV‐1), HSV‐2, varicella‐zoster virus (VZV), Epstein–Barr virus (EBV), cytomegalovirus (CMV), human herpes virus 6 (HHV‐6), HHV‐7, HHV‐8, adenovirus, BK virus (BKV), JC virus (JCV), parvovirus B19, and hepatitis B virus (HBV). Several viral DNAs were detected in 12 patients before hematopoietic stem cell transplantation. The detection rate gradually increased after transplantation and peaked at 21 days. The most frequently detected virus was HHV‐6 (n = 63; 60.0%), followed by EBV (n = 11; 10.5%), CMV (n = 11; 10.5%), and HHV‐7 (n = 9; 8.6%). Adenovirus and HBV were each detected in one patient (1.0%). Detection of HHV‐6 DNA was significantly more common among patients undergoing cord blood transplantation or with steroid treatment. EBV DNA tended to be more common in patients treated with anti‐thymocyte globulin. Multiplex PCR was useful for detecting many viral reactivations after hematopoietic stem cell transplantation, simultaneously. Cord blood transplantation, steroid treatment, or anti‐thymocyte globulin use was confirmed to be risk factors after transplantation. J. Med. Virol. 87:1427–1435, 2015. © 2015 Wiley Periodicals, Inc.

[1]  Human Herpesvirus , 2016, Red Book Atlas of Pediatric Infectious Diseases, 3rd Ed.

[2]  P. Lewalle,et al.  Detection of Herpesviridae in Whole Blood by Multiplex PCR DNA-Based Microarray Analysis after Hematopoietic Stem Cell Transplantation , 2014, Journal of Clinical Microbiology.

[3]  W. Jędrzejczak,et al.  Co-Infections with Cytomegalovirus and Human Herpesvirus Type 7 in Adult Polish Allogeneic Haematopoietic Stem Cell Transplant Recipients , 2013, Archivum Immunologiae et Therapiae Experimentalis.

[4]  I. Yakoub-Agha,et al.  Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[5]  D. Weisdorf,et al.  Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary? , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[6]  A. Skotnicki,et al.  Lymphotropic herpesvirus DNA detection in patients with active CMV infection – a possible role in the course of CMV infection after hematopoietic stem cell transplantation , 2011, Medical science monitor : international medical journal of experimental and clinical research.

[7]  Jing-bo Wang,et al.  [Monitoring of early Epstein-Barr virus reactivation and preemptive therapy after allogeneic hematopoietic stem cell transplantation]. , 2011, Zhonghua nei ke za zhi.

[8]  P. Chevallier,et al.  Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation , 2011, Leukemia.

[9]  D. Duda,et al.  Reactivations of cytomegalovirus, human herpes virus 6, and Epstein-Barr virus differ with respect to risk factors and clinical outcome after hematopoietic stem cell transplantation. , 2010, Transplantation proceedings.

[10]  I. Kerridge,et al.  Pre‐transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy , 2010, Transplant infectious disease : an official journal of the Transplantation Society.

[11]  P. Chevallier,et al.  Human herpes virus 6 infection is a hallmark of cord blood transplant in adults and may participate to delayed engraftment: a comparison with matched unrelated donors as stem cell source , 2010, Bone Marrow Transplantation.

[12]  P. O’Donnell,et al.  BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplants. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[13]  A. Guimarães,et al.  Association between oral HSV-1 and survival in allogeneic hematopoietic stem cell transplanted patients. , 2009, Medicina oral, patologia oral y cirugia bucal.

[14]  D. van Baarle,et al.  Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[15]  A. Lankester,et al.  Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning , 2007, European journal of haematology.

[16]  P. Lusso HHV-6 and the immune system: mechanisms of immunomodulation and viral escape. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[17]  K. Kashima,et al.  Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. , 2006, The Journal of infectious diseases.

[18]  M. Boeckh,et al.  Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  S. Chevret,et al.  Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. , 2004, Experimental hematology.

[20]  K. Yamanishi,et al.  High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. , 2002, Blood.

[21]  J Wagner,et al.  Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. , 2002, Blood.

[22]  E. Jaffe,et al.  Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. , 1999, Blood.

[23]  J. Peiris,et al.  Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease. Newcastle upon Tyne Bone Marrow Transport Group. , 1995, Bone marrow transplantation.

[24]  J. Peiris,et al.  Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease. Newcastle upon Tyne Bone Marrow Transport Group. , 1995, Bone marrow transplantation.

[25]  W W Wilke,et al.  Multiplex polymerase chain reaction. , 1992, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.